What Researchers Did
This study evaluated methods for distinguishing radiation necrosis from recurrent brain metastases and reviewed various treatment options.
What They Found
Radiation necrosis (RN) occurs in 5% to 25% of patients with brain metastases treated with stereotactic radiosurgery. Stereotactic biopsy remains the gold standard for diagnosis. Initial treatment often involves corticosteroids, antiangiogenic therapies, or hyperbaric oxygen therapy, with surgical resection or minimally invasive stereotactic laser ablation considered for refractory symptoms.
What This Means for Canadian Patients
Canadian patients with brain metastases undergoing stereotactic radiosurgery should be aware of radiation necrosis as a potential complication that requires careful differentiation from tumor recurrence. Accurate diagnosis, often via biopsy, is crucial to guide appropriate treatment, which can range from medication to surgical options like laser ablation.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The study primarily reviewed existing diagnostic and treatment approaches without presenting new primary research data or comparative outcomes.